NO20092770L - Nye aminopyrimidinderivater som PLK1-inhibitorer - Google Patents

Nye aminopyrimidinderivater som PLK1-inhibitorer

Info

Publication number
NO20092770L
NO20092770L NO20092770A NO20092770A NO20092770L NO 20092770 L NO20092770 L NO 20092770L NO 20092770 A NO20092770 A NO 20092770A NO 20092770 A NO20092770 A NO 20092770A NO 20092770 L NO20092770 L NO 20092770L
Authority
NO
Norway
Prior art keywords
lower alkyl
alkyl group
group
substituted
hydrogen atom
Prior art date
Application number
NO20092770A
Other languages
English (en)
Norwegian (no)
Inventor
Morihiro Mitsuya
Takashi Hhashihayata
Mikako Kawamura
Yoshiyuki Satoh
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Publication of NO20092770L publication Critical patent/NO20092770L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20092770A 2006-12-28 2009-07-27 Nye aminopyrimidinderivater som PLK1-inhibitorer NO20092770L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006356575 2006-12-28
JP2007265783 2007-10-11
PCT/JP2007/075224 WO2008081910A1 (en) 2006-12-28 2007-12-20 Novel aminopyrimidine derivatives as plk1 inhibitors

Publications (1)

Publication Number Publication Date
NO20092770L true NO20092770L (no) 2009-09-25

Family

ID=39588592

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20092770A NO20092770L (no) 2006-12-28 2009-07-27 Nye aminopyrimidinderivater som PLK1-inhibitorer

Country Status (24)

Country Link
US (1) US7977336B2 (zh)
EP (2) EP2114942B1 (zh)
JP (1) JPWO2008081914A1 (zh)
KR (1) KR101481388B1 (zh)
CN (1) CN101573361B (zh)
AR (1) AR064619A1 (zh)
AU (1) AU2007340530B2 (zh)
BR (1) BRPI0718966B8 (zh)
CA (1) CA2668738A1 (zh)
CL (1) CL2007003758A1 (zh)
CO (1) CO6190523A2 (zh)
CR (1) CR10784A (zh)
EC (1) ECSP099324A (zh)
GT (1) GT200900124A (zh)
IL (1) IL198675A0 (zh)
MA (1) MA31109B1 (zh)
MX (1) MX2009004920A (zh)
NO (1) NO20092770L (zh)
NZ (1) NZ577273A (zh)
PE (1) PE20081845A1 (zh)
RU (1) RU2458062C2 (zh)
SV (1) SV2009003258A (zh)
TW (1) TW200835485A (zh)
WO (2) WO2008081910A1 (zh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007337886C1 (en) 2006-12-22 2014-10-16 Astex Therapeutics Limited Bicyclic heterocyclic compounds as FGFR inhibitors
JP5442449B2 (ja) 2006-12-22 2014-03-12 アステックス、セラピューティックス、リミテッド 新規化合物
GB0720038D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New compounds
GB0720041D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New Compounds
GB0810902D0 (en) 2008-06-13 2008-07-23 Astex Therapeutics Ltd New compounds
WO2010013633A1 (ja) * 2008-07-31 2010-02-04 萬有製薬株式会社 細胞のｒｂステイタス及びｐｌｋ１阻害剤に対する感受性を予測する方法
JP4489132B2 (ja) * 2008-08-22 2010-06-23 株式会社東芝 磁気記録媒体の製造方法
GB0906470D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
GB0906472D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
US8445674B2 (en) 2009-10-21 2013-05-21 Hoffmann-La Roche Inc Heterocyclyl compounds
MX2012004990A (es) 2009-10-30 2012-06-12 Janssen Pharmaceutica Nv Deribados de imidazo [1,2-b] pirimideazina y su uso como inhibidores de la enzima fosfodiesterasa 10.
UY33213A (es) 2010-02-18 2011-09-30 Almirall Sa Derivados de pirazol como inhibidores de jak
AR080754A1 (es) 2010-03-09 2012-05-09 Janssen Pharmaceutica Nv Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
EP2463289A1 (en) 2010-11-26 2012-06-13 Almirall, S.A. Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors
WO2013000924A1 (en) 2011-06-27 2013-01-03 Janssen Pharmaceutica Nv 1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES
EP2554544A1 (en) 2011-08-01 2013-02-06 Almirall, S.A. Pyridin-2(1h)-one derivatives as jak inhibitors
WO2013046136A1 (en) 2011-09-27 2013-04-04 Novartis Ag 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
US9669035B2 (en) 2012-06-26 2017-06-06 Janssen Pharmaceutica Nv Combinations comprising PDE 2 inhibitors such as 1-aryl-4-methyl-[1,2,4]triazolo-[4,3-A]]quinoxaline compounds and PDE 10 inhibitors for use in the treatment of neurological of metabolic disorders
RU2667058C2 (ru) 2012-07-09 2018-09-14 Янссен Фармацевтика Нв Ингибиторы фермента фосфодиэстеразы 10
JP6324381B2 (ja) 2012-07-31 2018-05-16 クラウン バイオサイエンス インコーポレイテッド（タイカン） 抗ｅｇｆｒ薬物による処置のための非小細胞肺癌患者を同定するための組織学的マーカー
WO2014046617A1 (en) * 2012-09-19 2014-03-27 Agency For Science, Technology And Research Compositions and methods for treating cancer
JP6559228B2 (ja) 2014-09-17 2019-08-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 肥満症及び糖尿病の治療に有用なテトラヒドロイソキノリン誘導体及び医薬組成物
CN112592318B (zh) * 2020-12-12 2022-05-03 贵州医科大学 2-(4-甲氨酰基)苯胺基-4-氨基嘧啶衍生物及应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019790A (ja) 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US5223608A (en) 1987-08-28 1993-06-29 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
FI95708C (fi) 1988-10-31 1996-03-11 Eisai Co Ltd Analogiamenetelmä 1,4-diatsepiinijohdannaisen ja sen farmaseuttisesti sopivan suolan valmistamiseksi
JPH045029A (ja) 1990-04-23 1992-01-09 Bridgestone Corp 空気入りタイヤ
DK0547165T3 (da) 1990-09-28 2000-03-27 Smithkline Beecham Corp Fremgangsmåde til fremstilling af vandopløselige camptothecinanaloger såvel som forbindelserne 10-hydroxy-11-C(1-6)-alkoxyc
US5247089A (en) 1990-12-20 1993-09-21 North Carolina State University Method of making intermediates useful for the manufacture of camptothecin and camptothecin analogs
US5191082A (en) 1990-12-20 1993-03-02 North Carolina State University Camptothecin intermediate and method of making camptothecin intermediates
US5162532A (en) 1990-12-20 1992-11-10 North Carolina State University Intermediates and method of making camptothecin and camptothecin analogs
US5200524A (en) 1990-12-20 1993-04-06 North Carolina State University Camptothecin intermediates and method of making same
US5243050A (en) 1990-12-20 1993-09-07 North Carolina State University Alkylpyridone DE ring intermediates useful for the manufacture of camptothecin and camptothecin analogs
HU221343B1 (en) 1992-10-28 2002-09-28 Genentech Inc Use of anti-vegf antibodies for the treatment of cancer
JP3025602B2 (ja) 1993-05-21 2000-03-27 デビオファーム エス．アー． 光学的に高純度なシス−オキザラート（トランス−ｌ−１，２−シクロヘキサンジアミン）白金（ＩＩ）錯体の製造方法
GB9508538D0 (en) 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
EP0831880A4 (en) 1995-06-07 2004-12-01 Imclone Systems Inc ANTIBODIES AND FRAGMENTS OF ANTIBODIES INHIBITING TUMOR GROWTH
JP3154399B2 (ja) 1996-07-04 2001-04-09 デビオファーム エス．アー． 白金化合物の製造方法
AU784484B2 (en) * 1999-11-10 2006-04-13 Ortho-Mcneil Pharmaceutical, Inc. Substituted 2-aryl-3(heteroaryl)-imidazo(1,2-a) pyrimidines, and related pharmaceutical compositions and methods
US6703508B2 (en) 2000-12-04 2004-03-09 Sepracor, Inc. Methods for the stereoselective synthesis of substituted piperidines
US7196095B2 (en) 2001-06-25 2007-03-27 Merck & Co., Inc. (Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds
EP1414443B1 (en) 2001-08-01 2006-11-15 Merck & Co., Inc. BENZIMIDAZO 4,5-f|ISOQUINOLINONE DERIVATIVES
UA80296C2 (en) 2002-09-06 2007-09-10 Biogen Inc Imidazolopyridines and methods of making and using the same
JPWO2004043936A1 (ja) 2002-11-14 2006-03-09 協和醗酵工業株式会社 Ｐｌｋ阻害剤
JP5319113B2 (ja) 2004-03-26 2013-10-16 メチルジーン インコーポレイテッド ヒストンデアセチラーゼの阻害剤
JP4972804B2 (ja) * 2004-08-31 2012-07-11 Ｍｓｄ株式会社 新規置換イミダゾール誘導体

Also Published As

Publication number Publication date
EP2114942A4 (en) 2010-09-08
AU2007340530B2 (en) 2012-09-13
JPWO2008081914A1 (ja) 2010-04-30
PE20081845A1 (es) 2008-12-27
AU2007340530A1 (en) 2008-07-10
BRPI0718966A2 (pt) 2014-01-07
MX2009004920A (es) 2009-05-21
KR101481388B1 (ko) 2015-01-12
EP2116543A1 (en) 2009-11-11
RU2458062C2 (ru) 2012-08-10
RU2009128966A (ru) 2011-02-10
CN101573361B (zh) 2012-05-30
NZ577273A (en) 2011-03-31
KR20090092822A (ko) 2009-09-01
CA2668738A1 (en) 2008-07-10
BRPI0718966B1 (pt) 2020-11-17
EP2114942B1 (en) 2012-10-31
SV2009003258A (es) 2010-08-23
ECSP099324A (es) 2009-06-30
WO2008081910A1 (en) 2008-07-10
US20080305081A1 (en) 2008-12-11
BRPI0718966B8 (pt) 2021-05-25
CL2007003758A1 (es) 2008-07-04
MA31109B1 (fr) 2010-01-04
GT200900124A (es) 2010-11-03
US7977336B2 (en) 2011-07-12
WO2008081914A1 (ja) 2008-07-10
TW200835485A (en) 2008-09-01
CN101573361A (zh) 2009-11-04
CR10784A (es) 2009-09-16
CO6190523A2 (es) 2010-08-19
EP2116543A4 (en) 2010-09-08
EP2114942A1 (en) 2009-11-11
IL198675A0 (en) 2010-02-17
AR064619A1 (es) 2009-04-15

Similar Documents

Publication Publication Date Title
NO20092770L (no) Nye aminopyrimidinderivater som PLK1-inhibitorer
WO2008136444A1 (ja) 縮合複素環誘導体
NO20074763L (no) (1,5-difenyl-1H-pyrazol-3-yl)oksadiazolderivater, fremgangsmate ved fremstilling derav og anvendelse av samme i terapi
NO20051051L (no) Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme i terapeutiske midler
WO2009095792A3 (en) Substituted heteroarylamide diazepinopyrimidone derivatives
NO20082976L (no) Svovelholdige cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer
RS54260B1 (en) AMINODIHYDROTIAZINE DERIVATIVES AS BACE INHIBITORS FOR ALZHEIMER DISEASE TREATMENT
NO20092286L (no) Nitrogenhaldige heterosykliske forbindelser og anvendelse derav
NO20082388L (no) Heteroaryl substituerte piperidinderivater som L-CPT1 inhibitorer
MY153393A (en) Amino nicotinic and isonicotinic acid derivatives as dhodh as inhibitors
MX2010003445A (es) Derivados de nicotinamida, su preparacion y su uso terapeutico.
NO20081464L (no) 1-heterocyklusulfonyl, 2-aminometyl, 5-(hetero-)aryl subsidiert 1-H-pyrrol-derivater som syresekresjonsinhibitorer
UA116794C2 (uk) Моноциклічна піридинова похідна
MY169179A (en) Novel piperidine compound or salt thereof
MX2010008360A (es) Derivados de oxazepinopirimidona heteroarilamida sustituidos.
MX2011009146A (es) Sales de adicion de aminas que contienen grupos hidroxilo y/o carboxilicos con derivados de acido aminonicotinico como inhibidores de dhodh.
NO20074311L (no) Kinazolinderivat med tyrosinkinase-inhiberendeaktivitet
WO2008155668A3 (en) Heteroarylamide pyrimidone compounds
MX2009011769A (es) Derivados de piridona como inhibidores de mapk p38a.
MX2010008361A (es) Derivados de arilamida oxazepinopirimidona sustituidos.
MX2011011281A (es) Compuesto de carbinol que tiene un enlazante heterociclico.
WO2008051533A3 (en) Benzimidazole compounds
EA201071012A1 (ru) Производные азетидинов, способ их получения и применение их в терапии
WO2008155670A3 (en) Arylamide pyrimidone compounds
CO5650235A2 (es) Derivados de imidazol

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application